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Sugarcane biopolymer patch in femoral vein
angioplasty on dogs
Silvio Romero de Barros-Marques, PhD, Esdras Marques-Lins, PhD,
Maria Cláudia Sodré de Albuquerque, PhD, and José Lamartine de Andrade-Aguiar, PhD, Recife, Brazil
Purpose: To evaluate the use of the sugarcane biopolymer membrane in femoral vein patch angioplasty on dogs.
Methods: Eight dogs were submitted to bilateral femoral vein patch angioplasty with a sugarcane biopolymer membrane
patch on one side and an expanded polytetrafluoroethylene (e-PTFE) patch on the contralateral side. This research was
performed at Experimental Surgical Research Laboratory of the Centro de Ciências da Saúde at Universidade Federal de
Pernambuco. The dogs underwent new surgery at 180 days after the patch angioplasty in order to harvest the femoral
vein. All the animals were evaluated by clinical examination, measure of femoral vein diameter, venogram, and Doppler
fluxometry. The material harvested was sent for histologic study. Each animal served as its own control.
Results: In all veins of both groups, there were no cases of infection, rupture, or pseudoaneurysm formation and
thrombosis. In both groups, a chronic inflammatory reaction was observed, with lymphocytes, neutrophils, and fibrosis
in the outer surface of the patches. Fibrosis was seen in the inner surfaces of all the patches. In e-PTFE patches, invasion
by fibroblasts occurred.
Conclusions: The sugarcane biopolymer membrane can be used as a patch in femoral vein angioplasty on dogs. (J Vasc
Surg 2012;55:517-21.)
Clinical Relevance: The sugarcane biopolymer membrane is easily synthesized with a low cost of production. This
membrane has been used in many areas of experimental surgery as in the healing of skin wounds, in urinary
reconstruction, in reconstruction of tympanic membrane, and as an arterial substitute, but there is no report of its use as
a vein substitute. In order to evaluate the possibility of using the sugarcane biopolymer membrane in venous
reconstructive surgery, this study analyzed its utilization in femoral vein patch angioplasty.
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tAlthough there has been technological development
that permits the production of better vessel substitutes, the
search for an ideal material still continues, especially for use
in veins, not only because of its particular anatomic
characteristics but also because of the low blood pressure
in the venous circulation. The perfect substitute has to
present the right technical properties for its application
in humans as well as a low cost of production to allow its
wide utilization.1-8
Several researches have evaluated the use of new mate-
rials for the substitution of blood vessels. These studies
have shown the advantages of them compared with the
traditional vessel substitutes. A special group of materials
has been studied; they are produced from many species
of microorganisms and show similar characteristics to
human tissues, such as elastic properties and resistance to
rupture.6-9
Among these microorganisms, there are some types of
bacterial microorganisms that have the ability to synthesize
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doi:10.1016/j.jvs.2011.05.047olysaccharides and excrete them out of the cell as soluble
r nonsoluble polymers, which have been used in several
reas of medical research.9-11
An extracellular polysaccharide was produced through
icrobiology synthesis at Industrial Microbiological Labo-
atory of the Sugarcane Experimental Station at Carpina/
niversidade Federal Rural de Pernambuco and purified
or biological use at Experimental Surgical Research Labo-
atory/Universidade Federal de Pernambuco. This poly-
accharide was produced from sugarcane molasses and was
amed sugarcane biopolymer. The membrane obtained
rom this biopolymer was evaluated through laboratory
ests and showed high biocompatibility in addition to low
ytotoxicity.12,13
The sugarcane biopolymer membrane is easily synthe-
ized with a low production cost. This membrane has been
sed in many areas of experimental surgery, such as in the
ealing of skin wounds, in urinary reconstruction, in recon-
truction of tympanic membrane, and as an arterial substi-
ute, but there is no report of its use as a vein substitute. In
rder to evaluate the possibility of using the sugarcane
iopolymer membrane in venous reconstructive surgery,
his study evaluates its utilization in femoral vein patch
ngioplasty.14-17
ETHODS
Eight adult dogs (Canis familiaris) weighing on aver-
ge 15.44 kg (seven males and one female), were used in
his study. The animals were housed in the laboratory for a
1-day period prior to surgery. They were fed with com-
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February 2012518 Romero de Barros-Marques et almercial dog food, vaccinated against rabies (hydrophobia),
and received a dose of vermicide.
A 24-hour period of fasting from solid food was ob-
served for all dogs before the operation. The dogs were
anesthetized intravenously with sodium thiopental (dos-
age, 12.5 mg/kg), pancuronium bromide (dosage, 0.2
mg/kg), and ketamine hydrochloride (dosage, 2.5 mg/
kg), were intubated and underwent assisted ventilation,
and then bilateral femoral Doppler fluxometry (which uses
the ultrasonographic Doppler effect to evaluate the blood
flow in the veins) was performed. After this, the femoral
region was prepared and draped in a sterile fashion.
The access to the left and right femoral veins was made
via a 5-cm longitudinal incision on the skin and subcutane-
ous tissue, and themacroscopic measure of the femoral vein
diameter was taken. Femoral vein patch angioplasty was
done by sewing a 1.5  0.5-cm sugarcane biopolymer
membrane patch (0.2 mm of thickness and maximal size of
1.5  0.5 cm) on the left side and an expanded polytetra-
fluoroethylene (e-PTFE) patch on the right side with a
continuous 7-0 polypropylene suture. The sugarcane
biopolymer membrane is a cellulosic exopolysaccharide
produced from sugarcane molasses by Zooglea sp at Indus-
trial Microbiological Laboratory of the Sugarcane Experi-
mental Station at Carpina/Universidade Federal Rural de
Pernambuco and purified for biological use at Experimen-
tal Surgical Research Laboratory/Universidade Federal de
Pernambuco. After recovering from anesthesia, the dogs
were isolated in cages inside the laboratory and were fed
within 8 hours after having undergone surgery.
They were submitted to daily clinical evaluation for the
first week and then weekly thereafter. The end point for
Table. Femoral vein diameter before and after the angiopl
Variables Statistics
Femoral vein diameter before angioplasty Arithmetic meana
Mediana
Standard errora
CV (%)
Minimuma
Maximuma
Femoral vein diameter after angioplasty Arithmetic meana
Mediana
Standard errora
CV (%)
Minimuma
Maximuma
Variation (diameter before angioplasty 
diameter after angioplasty)
Arithmetic meana
Mediana
Standard errora
CV (%)
Minimuma
p
CV, Coefficient of variation.
aMeasure in cm.
bWilcoxon test.vessel harvest was 6months. All the animals were submitted to a new surgical procedure after 6 months, observing the
ame conditions of anesthesia and access as those used for
he first surgery. The abdominal region was also prepared
nd draped in a sterile fashion. The femoral veins were
xposed, and gross evaluation was performed. Doppler
uxometry and the macroscopic measure of the diameter of
he femoral veins were performed, an abdominal longitu-
inal incision was made to expose the vena cava for angio-
raphic access, and biplanar venography was taken.
After the venograms were obtained, each femoral vein
as harvested and sent to the Histopathology Laboratory
t Hospital das Clínicas at Universidade Federal de Per-
ambuco. The animals were then killed. All the experi-
ents were performed at Experimental Surgical Research
aboratory of the Centro de Ciências da Saúde at Uni-
ersidade Federal de Pernambuco from January 2005 to
ecember 2006. The experiments were divided into two
roups: an experimental group with eight sugarcane
iopolymer membrane patches and a control group with
ight e-PTFE patches. Each animal served as its own
ontrol.
ESULTS
All the animals survived during the experimental period
f 180 days and no cases of infection, rupture, pseudoan-
urysm formation, or thrombosis were observed at clinical
xamination in both groups. There were no statistical dif-
erences in the femoral vein diameter before and 180 days
fter angioplasty (P .05 byWilcoxon test; Table). In both
roups, a chronic inflammatory reaction with lymphocytes,
eutrophils, and fibrosis in the outer surface of the patches
as observed. Fibrosis was seen in the inner surfaces of all
according to the material used
Material
PExperimental (n  8) PTFE (n  8)
0.575 0.513 Pb  .125
0.550 0.500
0.089 0.064
15.416 12.505
0.500 0.40
0.700 0.60
0.575 0.513 Pb  .125
0.550 0.500
0.089 0.064
15.416 12.505
0.500 0.400
0.700 0.600
0.000 0.000 Pb  1.000
0.000 0.000
0.000 0.000
0.000 0.000
0.000 0.000
Pb  1.000 Pb  1.000asty,he patches. The new inner and adventitial layers were
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Volume 55, Number 2 Romero de Barros-Marques et al 519firmly bound to the surfaces of the patches. In both groups,
there were no cases of degenerative process and calcifica-
tion. In e-PTFE patches, invasion by fibroblasts was ob-
served (Figs 1-4).
DISCUSSION
The concept of the patch angioplasty was first estab-
lished by Carrel in 1906, but this surgical technique was
only widely used after the reports of Senning and Craw-
ford et al in 1959, which, in different studies, showed
that the use of a patch could help avoid stenosis after an
arteriotomy.18,19
Several biological materials have performed well when
they were used in the reconstructive surgery of the vena
cava in oncological patients. In the last decade, heterolo-
gous vessel substitutes of bovine pericardium, homologous
saphenous vein, and synthetic materials have been used in
Fig 1. Femoral vein patch angioplasty using sugarcane biopoly-
mer membrane. In the same figure, it is possible to see the femoral
artery with the sugarcane biopolymer patch.
Fig 2. Femoral vein and artery patch angioplasty using sugarcane
biopolymer membrane after 180 days.superior vena cava patch angioplasty and in artery patch rngioplasty. The major complications with the use of the
atches are similar to those of the other kind of arterial
ubstitutes: thrombosis, rupture or pseudoaneurysm for-
ation, and operatory wound infection.20-27
The rate of aneurismal formation and resistance to
upture of bovine pericardium, Dacron, PTFE, and greater
aphenous vein have been reported in the literature. Biasi et
l, in 2002, reported no cases of rupture or aneurismal
ormation by the use of bovine pericardium patch angio-
lasty during carotid endarterectomy in 323 cases. Miy-
motto et al, in 2009, in an experimental study comparing
ovine pericardium patch with greater saphenous vein
atch, concluded that the bovine pericardium patch had a
igher rupture resistance than that observed in the greater
aphenous vein group. Lord et al, in 1989, reported that
TFE patches, when used after carotid endarterectomy,
ig 3. Sugarcane biopolymer (SB) patch with chronic inflamma-
ory reaction in the outer surface (OS) and without invasion by
broblasts.
ig 4. Invasion of expanded polytetrafluoroethylene (e-PTFE)
atch by fibroblasts and chronic inflammatory reaction in the outer
urface (OS).esisted dilatation better than saphenous vein patches. In
d
m
s
n
l
t
h
m
s
e
a
b
s
c
c
i
w
I
t
w
t
s
b
t
t
c
C
u
A
C
A
D
W
C
F
S
O
O
S
R
JOURNAL OF VASCULAR SURGERY
February 2012520 Romero de Barros-Marques et althis study, dilatation was observed in 9.23% of the PTFE
patches and in 17% of the saphenous vein patches. Menon
et al, in 1973, in an experimental study performed on dogs,
reported only one case of dilation in 30 Dacron patch
angioplasties over the abdominal aorta and carotid and
femoral arteries.23,28-30
The time of clinical observation in the experimental
studies using patches has been varied. The time course used
in this study to evaluate the patches was the same reported
by Sarac et al in 2006, when they described the efficacy of
bovine peritoneum/fascia patches in femoral artery angio-
plasty on dogs. A time course smaller than used in the
present study was reported by Benzel et al, in 1992, when
they evaluated the autogenous canine fascia lata, Gore-Tex,
lyophilized human fascia lata, and autogenous canine
vein as a patch in carotid and femoral artery angioplasty.
In this case, the time course ranged from 6 to 12 weeks.
Pena and Husni, in 1968, compared autogenous vein
with Dacron in femoral artery patch angioplasty on dogs,
and the time course of the study ranged from 2 weeks to
9 months.20,25,31
In the present study, there were no clinical complica-
tions. The results were confirmed through clinical evalua-
tion, Doppler fluxometry, angiography, and the measure of
femoral vein diameter. These results are similar to other
experimental studies as were reported by Aguiar et al in
2007 with the use of sugarcane biopolymer patch in femo-
ral artery angioplasty on dogs, but in this case, they worked
with a high blood pressure system. The high rates of
complications of the earlier experimental studies with
patches were a consequence of the use of inappropriate
materials in vessel anastomosis. Those complications can
also occur due to the failure of the material used, as it was
observed by McCready et al in 2005. They showed the
high rate of pseudoaneurysm formation with the utiliza-
tion of small intestinal submucosa patches in carotid
angioplasties.17,27
The healing process of a vessel substitute is a conse-
quence of the reactions that occur among its wall and the
organic tissues that are related to it. The healing process is
considered good when these tissues invade the patch or
bind firmly to it. The present study showed the presence of
a chronic inflammatory reaction in the outer surface of the
sugarcane biopolymer patches and fibrosis on both sur-
faces. There were no cases of degenerative process, with
destruction of the integrity of the patches as occurred with
autogenous substitutes. This inflammatory reaction and the
fibrosis also occur with the synthetic prosthesis, including
e-PTFE. The rare presence of macrophages in both groups
confirms the low antigenic capacity of the two materials
used. Also similar to synthetic prosthesis, there were no
cases of calcification. Similar histologic results were ob-
tained by Aguiar et al in 2007, when they evaluated sugar-
cane biopolymer patches after 180 days of femoral artery
angioplasty on dogs.17
In a different way of synthetic prosthesis, sugarcane
biopolymer patches did not allow invasion by fibroblasts.
The invasion observed in the e-PTFE patches has beenescribed in the literature and occurred because they are
icroporous, which allows the cellular migration. The
ugarcane biopolymer patches are not porous and so did
ot allow the invasion, but the new inner and adventitial
ayers were firmly bound to them. This behavior is similar to
he healing process of the biological prosthesis, as in the
uman umbilicus cord vein, that also does not allow cellular
igration. The lack of tissue ingrowth observed in the
ugarcane biopolymer patches was also reported by Klemm
t al in 2001, when they evaluated the cellulose membrane
s a small vessel substitute but, in both cases (sugarcane
iopolymer patches and cellulose membrane), the outer
urface of the material was firmly bound to the surrounding
onnective tissue.9,32-34
Apart from the cost, the main advantage of the sugar-
ane biopolymer membrane when compared with PTFE is
ts low porosity; because of this, there was less bleeding
ith the sugarcane biopolymer patches during the suture.
n a different way, the PTFE patches permitted invasion of
he connective tissue (fibroblasts), which did not occur
ith the sugarcane biopolymer patches. In the last case,
hough, the connective tissue was firmly bound to the outer
urface of the patches. Another advantage of the sugarcane
iopolymer patch is its thickness, which is closer to the vein
hickness when compared with PTFE patches. In addition,
he sugarcane biopolymer patch is more flexible. These two
haracteristics make it easier to suture.
ONCLUSION
The sugarcane biopolymer membrane patch can be
sed in femoral vein angioplasty on dogs.
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